.
.
.
.
Coronavirus

Indonesia study finds China’s Sinovac vaccine highly effective in health workers

Published: Updated:

An analysis of Indonesian healthcare workers inoculated with a COVID-19 vaccine developed by China’s Sinovac Biotech showed it was 98 percent effective at preventing death and 96 percent effective at preventing hospitalization, a health ministry official said.

For more coronavirus news, visit our dedicated page.

The preliminary study was done from data on healthcare workers in the Indonesian capital Jakarta who had received the CoronaVac vaccine between January and March this year, lead researcher and health official Pandji Dhewantara said on Wednesday.

For all the latest headlines follow our Google News channel online or via the app.

Read more:

Europe medicines watchdog begins review of China’s Sinovac vaccine

Sinovac vaccine may not trigger sufficient antibody response to Brazil variant: Study

Indonesia approves China’s Sinopharm COVID-19 vaccine for emergency use